Gelfand J A, Boss G R, Conley C L, Reinhart R, Frank M M
Medicine (Baltimore). 1979 Jul;58(4):321-8. doi: 10.1097/00005792-197907000-00004.
A case of acquired C1INH deficiency with angioedema is described. Fifteen cases are thus far recorded. The clinical syndrome of angioedema in these patients closely resembles hereditary angioedema (HAE). Most cases are associated with a paraprotein, cryoglobulin, or autoantibody, which presumably initiates C1 activation and C1 Inhibitor consumption. C1INH, C4 and C2 levels are low in acquired C1INH deficiency, as in HAE. A distinguishing feature is that C1 titers are very low in the acquired disease and only minimally depressed, if at all, in HAE. Most cases have appeared in patients with an underlying lymphoproliferative or autoimmune disease. Therapy is directed at the underlying disorder, but androgen therapy may be helpful in preventing attacks. Future potential therapeutic approaches are discussed.
本文描述了一例伴有血管性水肿的获得性C1抑制物(C1INH)缺乏症病例。迄今为止共记录了15例。这些患者血管性水肿的临床综合征与遗传性血管性水肿(HAE)极为相似。大多数病例与副蛋白、冷球蛋白或自身抗体有关,推测这些物质会引发C1激活和C1抑制物消耗。与HAE一样,获得性C1INH缺乏症患者的C1INH、C4和C2水平较低。一个显著特征是,在获得性疾病中C1滴度非常低,而在HAE中即使有降低也只是轻微降低。大多数病例出现在患有潜在淋巴增殖性疾病或自身免疫性疾病的患者中。治疗针对潜在疾病,但雄激素治疗可能有助于预防发作。文中还讨论了未来潜在的治疗方法。